FOCL stock news · Edap TMS

Stories about Edap TMS (FOCL) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for FOCL

Follow Edap TMS (FOCL) free. When we publish a story about it, you get the plain-English explanation as an alert.

Free on the App Store and Google Play, or on the web.

Nov 5, 2026, 5:21 PM ET · Results
Edap TMS shared its Q3 2026 earnings, showing $9.8 million in HIFU sales, up 26% from last year.
Neutral
Edap TMS's HIFU revenue rose 26% to $9.8 million, but delays left revenue below expectations. Growth and margin gains balance costs and the miss, leaving the outlook unchanged.
Aug 13, 2026, 5:45 PM ET · Results
Complete transcript of Edap TMS's Q2 2026 earnings conference.
Neutral
Edap TMS, now Focal Therax, has reported strong second-quarter earnings with a 39% revenue increase, driven by growth in its HIFU segment. The company is also expanding its market presence and improving margins, which positions it favorably for future growth.